Posts Tagged ‘economic development’

October 25th, 2011

Global supply chains – should we go back in time?

Corporations seem to be rethinking their offshoring strategies. Thirty years ago, North American corporations decided that the best way to cut costs was to move their manufacturing to Asian and other developing countries. Now they’re rethinking the relevance of this strategy for various reasons, including rising production costs in China and India, increasingly volatile transportation costs, the higher risk of supply chain disruptions when doing business in faraway locations, and issues concerning quality control and intellectual property protection in poorly regulated markets. But there are also positive aspects to consider when contemplating whether to repatriate your manufacturing to North America such as access to skilled labour, easy adoption of automated manufacturing and access to a large transportation network. These factors are making business leaders rethink their “Invented here, made there” strategy. (more…)


October 12th, 2011

The role and impact of regional trade promotion organizations (ORPEX)

In June, the Quebec export commissioners network (RECOMEX) made up of 16 regional trade promotion organizations (ORPEX) across Quebec, such as the LAVAL TECHNOPOLE International Business Centre, published its annual report. Born of its members’ desire to share their expertise and networks of international contacts, RECOMEX has become “a regional force for SMEs that want to go global.” Here are a few of the 2010-2011 results presented by RECOMEX for ORPEXs: (more…)


September 18th, 2010

Combining exports and foreign investments – a winning model

Seventeen American biopharmaceutical firms participated in the North American Bio Forum 2010, created with a view to furthering alliances between five CROs in the Biotech City – Algorithme Pharma, Cirion, Corealis, LAB and Warnex – and the U.S. biopharmas.

This event was developed together with our five CROs. In fact, it was during a conversation with one of them that the idea for scientific conferences with buyer meetings was conceived. We then approached the others to gauge their interest in the project, whose overriding objective was to further alliances between our CROs and U.S. firms.

This is a unique event because by inviting companies to Laval, we also help increase foreign investment. The fact is that every dollar spent by the U.S. biopharmas in a Laval CRO is a dollar invested in R&D in Laval and in Quebec. The investments are extremely important because they lead to wealth creation in Laval.

The initial results are already encouraging. Not only have the participants written to tell us how satisfied they were with the event, particularly the solid meetings with potential R&D partners, but negotiations are underway to formalize partnerships. I believe concrete sales will soon follow. Finally, some firms have already expressed an interest in setting up operations in the Biotech City.

To see organizations like the International Business Centre combine exporting and investments is rather unusual. The tendency is to work on each aspect separately but the truth is you get more synergy by addressing them together.

I’m convinced that our strategy will lead to a winning economic development model. Time will tell if I’m right.

Véronique Proulx, MBA